L-Carnitine is a natural substance in the body that is needed for mammalian energy metabolism. Its main function is to promote lipid metabolism. In the case of hypoxia and ischemia, it reduces the accumulation of acyl-CoA, reduces the inhibition of adenine nucleotide translocase, and allows oxidative phosphorylation to proceed smoothly. It is the main energy source for muscle cells, especially myocardial cells, and provides fatty acid oxidation energy for tissues and organs such as the brain and kidneys. It increases the activity of NADH cytochrome C reductase and cytochrome oxidase, accelerates ATP production, and participates in drug detoxification. In addition, it also has the oxidation of medium-chain fatty acids, the oxidation of fatty acid peroxidase, buffers the ratio of bound coenzyme A to free coenzyme A, generates energy from ketones, pyruvate, and amino acids (including branched-chain amino acids), removes excessive coenzyme A toxicity, and regulates blood ammonia concentration.

It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.

It is a multi-component macrolide antibiotic produced by Streptomyces. Its antibacterial properties are similar to those of erythromycin. It has strong antibacterial effects on Gram-positive bacteria and mycoplasmas, and also has antibacterial effects on some Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus may still be sensitive to this product. It works by acting on the 50S subunit of the bacterial ribosome, hindering the synthesis of bacterial proteins, and is an antibacterial drug during the growth period.

This product is a beta-lactamase-stable cephalosporin bactericidal antibiotic. As a beta-lactam antibiotic, it works by blocking the synthesis of the main cell wall polymer, peptidoglycan. Because it can quickly penetrate the bacterial cell wall and bind to the target enzyme (penicillin binding protein) with high affinity, it can kill a wide spectrum of Gram-negative and Gram-positive pathogens at low concentrations. This has been confirmed in numerous in vitro studies on hospital-acquired and community-acquired pathogens worldwide, and recent studies have shown that its sensitivity has not changed. Many strains resistant to other injectable cephalosporins or aminoglycosides are still sensitive to this product.

This product is an antibiotic drug. Except for enterococci, methicillin-resistant and penicillin-resistant Staphylococcus aureus, it has good antibacterial activity against other Gram-positive cocci. Pneumococci and lytic streptococci are highly sensitive to this product. Diphtheria Corynebacterium, anthrax Bacillus, Listeria and Clostridium are sensitive to this drug. This product has stronger antibacterial activity against Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae than cephalothin and cefotaxime, but its antibacterial effect against Pseudomonas aeruginosa is worse than the latter two. Salmonella typhi and Shigella are sensitive to this drug, while other Enterobacteriaceae, Acinetobacter and Pseudomonas aeruginosa and Bacteroides fragilis are resistant. Neisseria is quite sensitive to this product, while influenza bacilli are only moderately sensitive.

This product is an antibiotic drug. Except for enterococci, methicillin-resistant and penicillin-resistant Staphylococcus aureus, it has good antibacterial activity against other Gram-positive cocci. Pneumococci and lytic streptococci are highly sensitive to this product. Diphtheria Corynebacterium, anthrax Bacillus, Listeria and Clostridium are sensitive to this drug. This product has stronger antibacterial activity against Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae than cephalothin and cefotaxime, but its antibacterial effect against high-content bacteria is weaker than the latter two. Salmonella typhi and Shigella are sensitive to this drug, while other Enterobacteriaceae, Acinetobacter and Pseudomonas aeruginosa and Bacteroides fragilis are resistant. Neisseria is quite sensitive to this product, while influenza bacilli are only moderately sensitive.